The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult patients. Kevzara has been approved as the first and only biologic indicated for PMR adult patients who did not respond to corticosteroids or who cannot tolerate corticosteroid taper. Developed using…...
Polymyalgia Rheumatica Research Study
Help Advance Polymyalgia Rheumatica (PMR) Research from Home and Earn $100 The Vasculitis Foundation is reaching out to the Polymyalgia Rheumatica (PMR) patient community to raise awareness about an opportunity for patients to help advance research from home. You need to be 18 years of age or older with PMR…...
